Actionnariat et activité des initiés pour Karyopharm Therapeutics Inc. (KPTI): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.70 |
| Capitalisation | $39M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-01 | Abate Kristin | S-Sale | 19 | $38 |
| 2026-07-28 | Poulton Stuart | S-Sale | 189 | $1K |
| 2026-05-21 | Oliger Christy J. | A-Award | 15,508 | |
| 2026-05-21 | PAKIANATHAN DEEPIKA | A-Award | 15,508 | |
| 2026-05-21 | Schor Chen | A-Award | 15,508 | |
| 2026-05-21 | Su Zhen | A-Award | 15,508 | |
| 2026-05-21 | BOHLIN GAREN G | A-Award | 15,508 | |
| 2026-05-21 | Greene Barry E | A-Award | 15,508 | |
| 2026-05-13 | Poulton Stuart | A-Award | 896 | |
| 2026-05-14 | Poulton Stuart | S-Sale | 403 | $4K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $49.7M | $69.0M | $118.0M | $128.9M | $85.9M | $190.5M | $135.2M | $52.2M | $62.5M | $60.5M |
| Placements à Court Terme | $79.9M | $77.5M | $210.2M | $133.1M | $163.3M | $38.2M | $142.8M | $139.2M | $46.2M | $3.2M |
| Créances | 0 | 0 | 0 | $7.9M | $12.9M | $22.5M | $47.1M | $27.0M | $30.8M | $26.2M |
| Stocks | 0 | 0 | 0 | $346000 | $2.6M | $4.1M | $4.2M | $3.0M | $4.7M | $4.0M |
| Actifs Courants | $131.6M | $148.4M | $334.6M | $278.6M | $276.5M | $275.6M | $350.2M | $233.9M | $156.5M | $103.1M |
| Immobilisations Corporelles | $2.8M | $2.2M | $3.9M | $13.7M | $11.6M | $9.6M | $7.4M | $4.9M | $6.3M | $4.7M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $180.4M | $180.3M | $341.2M | $295.0M | $313.1M | $305.3M | $358.2M | $240.4M | $164.4M | $108.4M |
| Dettes Fournisseurs | $4.8M | $5.7M | $4.3M | $985000 | $4.5M | $1.6M | $2.8M | $3.1M | $5.1M | $4.0M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $24.4M | $21.0M |
| Passifs Courants | $16.5M | $49.5M | $46.9M | $46.4M | $60.2M | $73.7M | $65.9M | $69.5M | $92.3M | $92.1M |
| Dette à Long Terme | 0 | 0 | $102.7M | $109.9M | $117.9M | $169.3M | $170.1M | $170.9M | $162.9M | $205.9M |
| Passifs Totaux | $18.1M | $50.8M | $158.0M | $245.2M | $262.5M | $385.0M | $374.8M | $376.6M | $350.4M | $401.3M |
| Réserves | -$366.1M | -$495.3M | -$673.7M | -$873.3M | -$1.07B | -$1.18B | -$1.34B | -$1.49B | -$1.56B | -$1.76B |
| Capitaux Propres | $162.2M | $129.5M | $183.2M | $49.8M | $50.5M | -$79.7M | -$16.7M | -$136.2M | -$186.0M | -$292.9M |
| Dette Totale | 0 | 0 | $102.7M | $124.7M | $131.1M | $180.6M | $179.1M | $177.0M | $194.5M | $233.6M |
| Dette Nette | -$129.6M | -$146.5M | -$225.5M | -$137.3M | -$118.1M | -$48.0M | -$98.9M | -$14.4M | $85.8M | $169.9M |
| Fonds de Roulement | $115.2M | $99.0M | $287.7M | $232.2M | $216.3M | $201.9M | $284.3M | $164.4M | $64.2M | $11.1M |
Santé financière
| Dette / Capitaux propres | -0.65 |
| Ratio de liquidité | 0.79 |
Rentabilité
| Rentabilité des capitaux propres | 77.63% |
| Rentabilité du capital investi | 376.87% |
| Rentabilité des actifs | -201.89% |
| Marge brute | 95.88% |
| Marge opérationnelle | -56.17% |
| Marge nette | -153.28% |
Entreprises liées: ALGS · BRNS · CVM · FGEN · INMB · MDCX · MRSN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de KPTI: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions